Assignee
NANOMAB TECH LIMITED
HK·5 granted patents·2 pending applications·14 citations·filing 2017–2022
Top patents by PatentIndex Score
7 records- 0188US10556954B2Anti-PD-L1 nanobody, coding sequence and use thereofNANOMAB TECH LIMITED·Filed 2017·Granted Feb 11, 2020·8 cites·12 claims
- 0285US11466085B2Anti-PD-L1 nanobody, coding sequence and use thereofNANOMAB TECH LIMITED·Filed 2019·Granted Oct 11, 2022·3 cites·8 claims
- 0379US11517632B2Anti-Her2 single chain antibody and coding sequence and use thereofNANOMAB TECH LIMITED·Filed 2018·Granted Dec 6, 2022·2 cites·14 claims
- 0475US11642418B2Use of radiolabeled nanobody in prognosis and diagnosis of cancerNANOMAB TECH LIMITED·Filed 2018·Granted May 9, 2023·1 cites·17 claims
- 0571US12083193B2Anti-Her2 nanobody and coding sequence and use thereofNANOMAB TECH LIMITED·Filed 2022·Granted Sep 10, 2024·0 cites·12 claims
- 0655US2024360248A1Anti-ptk7 single-domain antibody and application thereofNANOMAB TECH LIMITED·Filed 2022·Application pending·0 cites
- 0754US2024368302A1Anti-trop2 single-domain antibody and use thereofNANOMAB TECH LIMITED·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →